Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 15 November 2018




EFPIA Reaction to publication for the proposed Brexit Withdrawal Agreement
15 November 2018

EFPIA notes the publication of the withdrawal agreement under which terms the United Kingdom would leave the European... Read more

Delivering more for patients and health systems through outcomes-measurement
15 November 2018

A seminar hosted by the ABPI, ICHOM and EFPIA Read more




Antimicrobial Stewardship: Our contribution to #KeepAntibioticsWorking (Guest blog)
15 November 2018 - Claudie Charbonneau

A guest blog by Claudie Charbonneau, Senior Director, Patient & Health Impact and Infectious Diseases Global Team Lead... Read more

Global action on antibiotic awareness must progress (Guest blog)
15 November 2018 - Zuzana Kusynová

A guest blog by Zuzana Kusynová, policy advisor and project manager at FIP Read more


Infographic: Why new incentives are needed to develop antibiotics


Infographic: Why new incentives are needed to develop antibiotics
05 April 2018 (Publications)

As of May 2017, 51 antibiotics and 11 biologicals were in the clinical pipeline. Only five are expected to reach the... Read more


What we are reading


By 2050, superbugs may cost the economy $100 trillion
On 15 November 2018 (By Thomas Cueni, Director General, IFPMA)

Evidence suggests superbugs could cost the global economy up to 3.5% of GDP – and push 28 million more people... Read more